Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study - Wikidata - wikimedia - TriplyDB

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study

http://www.wikidata.org/entity/Q35073049

about

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine Suspected non-Alzheimer disease pathophysiology--concept and controversy A review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalus Overestimating the Effects of Healthy Aging Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech.Dementia.A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease Genetic variants in Alzheimer disease - molecular and brain network approaches Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 Quantile Regression Models for Current Status Data.Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.PART is part of Alzheimer disease.PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.PART and SNAP.At the crossroads of preclinical AD and normal brain ageing Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.Amyloid imaging for dementia in clinical practice.Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.Clinical Utility of Amyloid Imaging in a Complex Case of Corticobasal Syndrome Presenting with Psychiatric Symptoms Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging.A multicenter study of the early detection of synaptic dysfunction in Mild Cognitive Impairment using Magnetoencephalography-derived functional connectivity.Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease.Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.Massachusetts Alzheimer's Disease Research Center: progress and challenges.Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment The neuropathology and cerebrovascular mechanisms of dementia Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study Regional brain hypometabolism is unrelated to regional amyloid plaque burden.Atrial fibrillation, cognitive impairment, and neuroimaging Amyloid imaging for dementia in Canada Multimorbidity and neuroimaging biomarkers among cognitively normal persons The Impact of Age on Cognition Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information.Amyloid-β 1-24 C-terminal truncated fragment promotes amyloid-β 1-42 aggregate formation in the healthy brain.Immununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases.

P2860

Q26768648-D6EFF4E6-0180-42BD-830C-6703E485CEE9 Q26771270-2BABF113-78FF-473D-8A29-D613797ED744 Q26771308-99CC2806-B479-4D60-956C-DC96A2EC6007 Q26785333-1CF04F41-7FFD-46E1-B11F-8BE04D56A05B Q27317202-3E3B0BEF-2CF5-4819-A305-73F43C40F3E0 Q28081075-B31B996C-C217-483B-B7E0-436CB8E24016 Q28547333-64C0D59C-1CF7-4131-A6F0-3A9A8647059D Q28596011-4E6E54A5-0D4D-4122-ABE5-5FEF31BEFAE6 Q30981669-BC926EB1-A698-4260-97E1-F157EDD627C1 Q31150102-D439D9B0-F18A-44E8-898C-77B96C8D9024 Q33576727-A1B8EC0A-C337-48C7-B3EA-795A63F25123 Q34460027-69233D86-5D6B-47AE-AD40-5C21AC6DAFCC Q34467464-F2EB030D-583B-48DB-B17C-9A46CCFCA690 Q34507153-8464FB66-1582-4908-9EC0-BDE6E5C3661A Q34942007-6D9C153A-7611-4123-8C07-68A9C6B0C906 Q35529715-103E0685-D238-4571-AC82-AB76471FE7C2 Q35598271-2E30B9E3-9E3F-48D5-95FB-8F9482A7C297 Q35603195-1ED7FCE8-2D68-435B-9B89-047D1548C1C1 Q35690134-8297FCA1-AFE7-43BE-ABBC-9F1CBE13D317 Q35800785-0D42FE15-C841-4E4C-949B-21BF5707C720 Q35893095-BF591A81-F7A1-4FA0-9600-E2A17E6CFA3D Q35905536-71EE5D68-D1F0-45C3-855A-E4B77E3DD26E Q36005045-D5B2B2FE-865C-4127-B16E-32ED2C26B0A0 Q36265279-30AFC510-8B88-4E54-86CF-98205037FCFF Q36276506-7DC9F5ED-1136-4ADD-ADF1-F29A85E8794D Q36304325-CF337F82-59C9-4821-9E69-0B0D2302ECDC Q36305487-48AFBA81-B6A9-4BDE-919B-AF0062099FC7 Q36383749-2FF2E297-2E00-4E41-833D-CCCE920823A7 Q36528669-88A16684-2F5D-43C5-83B0-7375E2630CF6 Q36593201-51D312EF-0F23-4310-9856-D746AB4899DE Q36667836-7B80C4CC-04AD-4F07-BCFA-61D89FD8AE1C Q36726016-1138A4F5-0338-4E59-9A06-B8B629400370 Q36827384-DF3704DD-FD03-40E5-97B6-65A2268782D2 Q36905398-AA94378C-1595-4DCF-B2E4-B476520C6BBE Q36963306-0663AFFA-D106-481A-A2AA-3247B51F1836 Q37000400-9B496158-0B22-44A2-A838-8A77319DC8D8 Q37220632-DC21E4E6-000A-4D00-8303-5DF13FBBB7C7 Q37303038-902733BD-C056-4F10-A9EA-839BED41A0B4 Q37326344-FFD19591-6334-415B-9EDE-99BEFB3DFD31 Q37398778-A928C2F5-3B53-44D7-BCA2-F087E3E24825

P2860

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study

http://www.wikidata.org/entity/Q35073049

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Age-specific population freque ...... years: a cross-sectional study

@ast

Age-specific population freque ...... years: a cross-sectional study

@en

type

label

Age-specific population freque ...... years: a cross-sectional study

@ast

Age-specific population freque ...... years: a cross-sectional study

@en

prefLabel

Age-specific population freque ...... years: a cross-sectional study

@ast

Age-specific population freque ...... years: a cross-sectional study

@en

P1433

Q35073049-82436A2A-7CF1-40D9-9B78-227D7E1C0243

P1476

Q35073049-9CE51D10-BF8F-4D57-808B-2DC310CA4D2C

P2093

Q35073049-019193DB-B8F7-4EDC-85B8-E2742E2214E2

Q35073049-0C287F64-59DF-4306-B73D-CEDCC4D94FB2

Q35073049-30F43CFD-402A-4C14-BFE5-5C689A781348

Q35073049-557134CA-F059-4202-8C2E-F204AD83A66A

Q35073049-713EB6AA-2486-4905-9358-FB3FD029F8E8

Q35073049-9ECEA99D-34C5-49A5-8DFF-C5540B0C9358

Q35073049-A5792E3F-C99C-486B-9919-80C3A37EA8D3

Q35073049-BA80C540-61EC-4549-8E06-2364721F8DDF

Q35073049-E84C275C-7FC9-4975-AF7C-EF7E8C4DD767

Q35073049-EAF4C384-67DD-458F-840E-88381DC6C666

P2860

Q35073049-0A2041FE-EFDA-4B4A-AC31-BE29EB6CD7C8

Q35073049-12063584-0368-427E-B13C-369CB06B3DDD

Q35073049-1668ACE7-51A0-4263-A450-5124B1016740

Q35073049-1CC18614-7DCC-43B6-8CD8-C417EC57E722

Q35073049-2BBA365A-AF48-4414-B475-1766A56F7347

Q35073049-344BB505-9BAD-4966-B64E-40DF40625470

Q35073049-360C157E-24FC-4E30-9DFF-AB09EAA96615

Q35073049-39BEC360-9545-4161-819A-DBE8D2D5C273

Q35073049-40020851-396C-47B0-BF7A-C2EA35239717

Q35073049-50032338-E709-4662-A81D-263A80553F89

P304

Q35073049-6745CA91-7D3C-42E0-9687-CC65EC970251

P31

Q35073049-566E6498-07EF-463D-B227-267394687C0F

P356

Q35073049-7D623E4B-4641-4050-82DD-8791AAE6272D

P433

Q35073049-03F12598-E773-4086-89F9-4450673FABC8

P478

Q35073049-F3183C6F-C372-47B1-B47C-05D9531DDA81

P50

Q35073049-30BB45D3-FCCD-4928-9DDC-C76AB4664573

Q35073049-391C76B4-489D-4FC0-B495-5B5AF58DBA21

Q35073049-E547C116-E1FE-456A-B317-4E2BBD006D13

P577

Q35073049-C7606C10-90C2-4848-8AC0-9E8810EF3CE7

P698

Q35073049-A78B57E0-EA15-472E-BFA1-D0EEFBA6461C

P932

Q35073049-C49D7150-B1E0-40CB-804F-FA110B2CA22D

P356

S1474-4422(14)70194-2

P1433

Lancet Neurology

P1476

Age-specific population freque ...... years: a cross-sectional study

@en

P2093

Gregory M Preboske

http://www.w3.org/2001/XMLSchema#string

Heather J Wiste

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Gunter

http://www.w3.org/2001/XMLSchema#string

Matthew L Senjem

http://www.w3.org/2001/XMLSchema#string

Michelle M Mielke

http://www.w3.org/2001/XMLSchema#string

Prashanthi Vemuri

http://www.w3.org/2001/XMLSchema#string

Stephen D Weigand

http://www.w3.org/2001/XMLSchema#string

Val J Lowe

http://www.w3.org/2001/XMLSchema#string

Vernon S Pankratz

http://www.w3.org/2001/XMLSchema#string

Walter A Rocca

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration.

The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.

P304

997-1005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(14)70194-2

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Ronald C. Petersen

David S Knopman

P577

2014-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25201514

http://www.w3.org/2001/XMLSchema#string

P932

4324499

http://www.w3.org/2001/XMLSchema#string